pharmanews.eu Report : Visit Site


  • Ranking Alexa Global: # 10,769,035

    Server:nginx...
    X-Powered-By:PHP/5.4.16

    The main IP address: 82.165.156.109,Your server United States,Chesterbrook ISP:1&1 Internet AG  TLD:eu CountryCode:US

    The description :breaking european pharmaceutical news...

    This report updates in 14-Jul-2018

Technical data of the pharmanews.eu


Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host pharmanews.eu. Currently, hosted in United States and its service provider is 1&1 Internet AG .

Latitude: 40.075660705566
Longitude: -75.459083557129
Country: United States (US)
City: Chesterbrook
Region: Pennsylvania
ISP: 1&1 Internet AG

the related websites

    lundbeck.com worldpharmanews.com 

HTTP Header Analysis


HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

X-Powered-By:PHP/5.4.16
Transfer-Encoding:chunked
Set-Cookie:d4dad6935f632ac35975e3001dc7bbe8=0jk9birt2fb11dk4ge87v2nrg4; path=/; HttpOnly
Expires:Wed, 17 Aug 2005 00:00:00 GMT
Server:nginx
Last-Modified:Fri, 13 Jul 2018 18:13:00 GMT
Connection:keep-alive
Pragma:no-cache
Cache-Control:no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Date:Fri, 13 Jul 2018 18:13:00 GMT
Content-Type:text/html; charset=utf-8

DNS

soa:ns.udag.net. hostmaster.united-domains.de. 2015072501 10800 3600 604800 3600
ns:ns.udag.net.
ns.udag.de.
ns.udag.org.
ipv4:IP:82.165.156.109
ASN:8560
OWNER:ONEANDONE-AS Brauerstrasse 48, DE
Country:DE
mx:MX preference = 20, mail exchanger = mail.pharmanews.eu.
MX preference = 10, mail exchanger = mail.pharmanews.eu.

HtmlToText

pharmanews.eu search ... business r&d jobs ec ema events open calls pharmanews.eu welcome to the top european pharmaceutical news portal. stay updated on the latest pharma news. subscribe now, it's free! smi presents the 13th annual industry leading conference: cold chain distribution details business 11 july 2018 10 - 11 december 2018 , london, uk. the 13th annual event will specifically focus on recent advances in temperature-controlled logistic solutions and the impact of regulatory changes on this multi-billion-dollar industry. the event will also address the impact of the overwhelming digitalisation of the industry and how companies, from biotech’s to pharma, need to adapt, as well as the crucial challenges of supply chain visibility and data integrity in the cold chain industry. read more ... xantus programme confirms low bleeding and low stroke rate with xarelto® in 11,121 prospectively investigated patients with atrial fibrillation details bayer 10 july 2018 results from an analysis of bayer's xantus programme were recently published in the journal of the american college of cardiology (jacc)(1). the data confirm the safety profile of the oral factor xa inhibitor xarelto® (rivaroxaban) in routine clinical practice. the analysis highlighted low bleeding and low stroke rates in patients with atrial fibrillation (af) treated with xarelto, as well as low rates of treatment discontinuation. read more ... orphan drugs and rare diseases conference 2018 details events 09 july 2018 17 - 18 october, london, uk. patients with rare diseases cannot continue to be overlooked because of costly therapies and have the same rights to treatment as any other patient. at this year's orphan drugs and rare diseases conference, organised by smi group and taking place in london, industry experts will address the opportunities and challenges within the rare disease treatment field. read more ... researchers develop a new method for turning skin cells into pluripotent stem cells details research 06 july 2018 our bodies consist of many different kinds of cells, each with their own role. the japanese scientist shinya yamanaka had made earlier the discovery, earning the nobel prize in 2012, that cells from adult skin can be converted to cells typical of early embryos, so-called induced pluripotent stem cells (ipsc). this process is called reprogramming. read more ... data-sharing website may speed the response to new illegal drugs details research 05 july 2018 the drug overdose epidemic currently gripping the nation is so tenacious in part because it's being driven by fentanyl, a synthetic opioid that comes in many forms. each form has a slightly different chemical structure, and clandestine chemists are constantly cooking up new ones. from a law-enforcement perspective, this makes fentanyl a moving target and very difficult to control. read more ... new small molecules pave the way for treating autoinflammatory disease details research 04 july 2018 the innate immune system is the first line of defense, with cells that quickly identify "foreign" motifs from viruses and bacteria and mount up a counterattack to eliminate them. as a key strategy to sense the presence of pathogens, the cells of the innate immune system use receptors that can identify microbial dna and in turn activate a protein called sting (stimulator of interferon genes). once activated, sting turns on genes that help cells fight off the infecting pathogen. read more ... global study by novartis and european migraine and headache alliance reveals 60% of employed people with severe migraine miss, on average, a week of work per month details novartis 03 july 2018 novartis and the european migraine and headache alliance (emha) announced initial findings from the largest global migraine patient study to date, involving over 11,000 people from 31 countries. migraine is a neurological disease which can vary in severity with symptoms ranging from head pain, nausea, vomiting to sensitivity to light. read more ... more pharma news ... the west cancer center's dr. lee schwarzberg researches new therapeutic approaches in breast cancer first two car-t cell medicines recommended for approval in the european union amgen and novartis present new data demonstrating long-term efficacy, safety and tolerability of aimovig tm (erenumab-aooe) in patients with chronic and episodic migraine poliovirus therapy for recurrent glioblastoma has three year survival rate of 21 percent novartis clear about psoriasis survey data highlights challenges psoriasis patients face to achieve goal of clear skin immuno-oncology conference 2018 alzheimer's breakthrough: brain metals that may drive disease progression revealed you are here: about terms and conditions contact advertise top news channels business research ema events follow us didn't we got you connected? if not, please note the following magic buttons: facebook twitter rss 2.0 atom 1.0 newsletter stay updated on the latest pharma news. subscribe now, it's free! copyright © 2018 pharmanews.eu. all rights reserved. our top projects: world pharma news | world pharma jobs | pharmanews.eu | ehealthnews.eu | (health it) space

URL analysis for pharmanews.eu


http://www.pharmanews.eu/?format=feed&type=rss
http://www.pharmanews.eu/bayer
http://www.pharmanews.eu/events
http://www.pharmanews.eu/rd
http://www.pharmanews.eu/ema/1860-first-two-car-t-cell-medicines-recommended-for-approval-in-the-european-union
http://www.pharmanews.eu/ec
http://www.pharmanews.eu/?format=feed&type=atom
http://www.pharmanews.eu/research/1863-new-small-molecules-pave-the-way-for-treating-autoinflammatory-disease
http://www.pharmanews.eu/events/1856-immuno-oncology-conference-2018
http://www.pharmanews.eu/events/1866-orphan-drugs-and-rare-diseases-conference-2018
http://www.pharmanews.eu/business/1868-smi-presents-the-13th-annual-industry-leading-conference-cold-chain-distribution
http://www.pharmanews.eu/novartis
http://www.pharmanews.eu/research/1858-poliovirus-therapy-for-recurrent-glioblastoma-has-three-year-survival-rate-of-21-percent
http://www.pharmanews.eu/amgen/1859-amgen-and-novartis-present-new-data-demonstrating-long-term-efficacy-safety-and-tolerability-of-aimovig-tm-erenumab-aooe-in-patients-with-chronic-and-episodic-migraine
http://www.pharmanews.eu/contact

Whois Information


Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

% The WHOIS service offered by EURid and the access to the records
% in the EURid WHOIS database are provided for information purposes
% only. It allows persons to check whether a specific domain name
% is still available or not and to obtain information related to
% the registration records of existing domain names.
%
% EURid cannot, under any circumstances, be held liable in case the
% stored information would prove to be wrong, incomplete or not
% accurate in any sense.
%
% By submitting a query you agree not to use the information made
% available to:
%
% - allow, enable or otherwise support the transmission of unsolicited,
% commercial advertising or other solicitations whether via email or
% otherwise;
% - target advertising in any possible way;
%
% - to cause nuisance in any possible way to the registrants by sending
% (whether by automated, electronic processes capable of enabling
% high volumes or other possible means) messages to them.
%
% Without prejudice to the above, it is explicitly forbidden to extract,
% copy and/or use or re-utilise in any form and by any means
% (electronically or not) the whole or a quantitatively or qualitatively
% substantial part of the contents of the WHOIS database without prior
% and explicit permission by EURid, nor in any attempt hereof, to apply
% automated, electronic processes to EURid (or its systems).
%
% You agree that any reproduction and/or transmission of data for
% commercial purposes will always be considered as the extraction of a
% substantial part of the content of the WHOIS database.
%
% By submitting the query you agree to abide by this policy and accept
% that EURid can take measures to limit the use of its WHOIS services
% in order to protect the privacy of its registrants or the integrity
% of the database.
%
% The EURid WHOIS service on port 43 (textual whois) never
% discloses any information concerning the registrant.
% Registrant and onsite contact information can be obtained through use of the
% webbased whois service available from the EURid website www.eurid.eu
%
% WHOIS pharmanews.eu
Domain: pharmanews.eu

Registrant:
NOT DISCLOSED!
Visit www.eurid.eu for webbased whois.

Technical:
Name: Host Master
Organisation: united-domains AG
Language: de
Phone: +49.8151368670
Fax: +49.81513686777
Email: [email protected]

Registrar:
Name: united-domains AG
Website: https://www.united-domains.de

Name servers:
ns.udag.de
ns.udag.net
ns.udag.org

Please visit www.eurid.eu for more info.

  REFERRER http://www.eurid.eu

  REGISTRAR EURID

SERVERS

  SERVER eu.whois-servers.net

  ARGS pharmanews.eu

  PORT 43

  TYPE domain

DOMAIN

  NAME pharmanews.eu

REGISTRAR

  NAME united-domains AG

  URL https://www.united-domains.de

NSERVER

  NS.UDAG.DE 185.61.8.10

  NS.UDAG.NET 89.31.141.10

  NS.UDAG.ORG 185.61.8.11

OWNER
NOT DISCLOSED!
Visit www.eurid.eu for webbased whois.
Technical:
Name: Host Master
Organisation: united-domains AG
Language: de
Phone: +49.8151368670
Fax: +49.81513686777
Email: [email protected]

  REGISTERED yes

Go to top

Mistakes


The following list shows you to spelling mistakes possible of the internet users for the website searched .

  • www.upharmanews.com
  • www.7pharmanews.com
  • www.hpharmanews.com
  • www.kpharmanews.com
  • www.jpharmanews.com
  • www.ipharmanews.com
  • www.8pharmanews.com
  • www.ypharmanews.com
  • www.pharmanewsebc.com
  • www.pharmanewsebc.com
  • www.pharmanews3bc.com
  • www.pharmanewswbc.com
  • www.pharmanewssbc.com
  • www.pharmanews#bc.com
  • www.pharmanewsdbc.com
  • www.pharmanewsfbc.com
  • www.pharmanews&bc.com
  • www.pharmanewsrbc.com
  • www.urlw4ebc.com
  • www.pharmanews4bc.com
  • www.pharmanewsc.com
  • www.pharmanewsbc.com
  • www.pharmanewsvc.com
  • www.pharmanewsvbc.com
  • www.pharmanewsvc.com
  • www.pharmanews c.com
  • www.pharmanews bc.com
  • www.pharmanews c.com
  • www.pharmanewsgc.com
  • www.pharmanewsgbc.com
  • www.pharmanewsgc.com
  • www.pharmanewsjc.com
  • www.pharmanewsjbc.com
  • www.pharmanewsjc.com
  • www.pharmanewsnc.com
  • www.pharmanewsnbc.com
  • www.pharmanewsnc.com
  • www.pharmanewshc.com
  • www.pharmanewshbc.com
  • www.pharmanewshc.com
  • www.pharmanews.com
  • www.pharmanewsc.com
  • www.pharmanewsx.com
  • www.pharmanewsxc.com
  • www.pharmanewsx.com
  • www.pharmanewsf.com
  • www.pharmanewsfc.com
  • www.pharmanewsf.com
  • www.pharmanewsv.com
  • www.pharmanewsvc.com
  • www.pharmanewsv.com
  • www.pharmanewsd.com
  • www.pharmanewsdc.com
  • www.pharmanewsd.com
  • www.pharmanewscb.com
  • www.pharmanewscom
  • www.pharmanews..com
  • www.pharmanews/com
  • www.pharmanews/.com
  • www.pharmanews./com
  • www.pharmanewsncom
  • www.pharmanewsn.com
  • www.pharmanews.ncom
  • www.pharmanews;com
  • www.pharmanews;.com
  • www.pharmanews.;com
  • www.pharmanewslcom
  • www.pharmanewsl.com
  • www.pharmanews.lcom
  • www.pharmanews com
  • www.pharmanews .com
  • www.pharmanews. com
  • www.pharmanews,com
  • www.pharmanews,.com
  • www.pharmanews.,com
  • www.pharmanewsmcom
  • www.pharmanewsm.com
  • www.pharmanews.mcom
  • www.pharmanews.ccom
  • www.pharmanews.om
  • www.pharmanews.ccom
  • www.pharmanews.xom
  • www.pharmanews.xcom
  • www.pharmanews.cxom
  • www.pharmanews.fom
  • www.pharmanews.fcom
  • www.pharmanews.cfom
  • www.pharmanews.vom
  • www.pharmanews.vcom
  • www.pharmanews.cvom
  • www.pharmanews.dom
  • www.pharmanews.dcom
  • www.pharmanews.cdom
  • www.pharmanewsc.om
  • www.pharmanews.cm
  • www.pharmanews.coom
  • www.pharmanews.cpm
  • www.pharmanews.cpom
  • www.pharmanews.copm
  • www.pharmanews.cim
  • www.pharmanews.ciom
  • www.pharmanews.coim
  • www.pharmanews.ckm
  • www.pharmanews.ckom
  • www.pharmanews.cokm
  • www.pharmanews.clm
  • www.pharmanews.clom
  • www.pharmanews.colm
  • www.pharmanews.c0m
  • www.pharmanews.c0om
  • www.pharmanews.co0m
  • www.pharmanews.c:m
  • www.pharmanews.c:om
  • www.pharmanews.co:m
  • www.pharmanews.c9m
  • www.pharmanews.c9om
  • www.pharmanews.co9m
  • www.pharmanews.ocm
  • www.pharmanews.co
  • pharmanews.eum
  • www.pharmanews.con
  • www.pharmanews.conm
  • pharmanews.eun
  • www.pharmanews.col
  • www.pharmanews.colm
  • pharmanews.eul
  • www.pharmanews.co
  • www.pharmanews.co m
  • pharmanews.eu
  • www.pharmanews.cok
  • www.pharmanews.cokm
  • pharmanews.euk
  • www.pharmanews.co,
  • www.pharmanews.co,m
  • pharmanews.eu,
  • www.pharmanews.coj
  • www.pharmanews.cojm
  • pharmanews.euj
  • www.pharmanews.cmo
Show All Mistakes Hide All Mistakes